Enhanced susceptibility of cis‐diamminedichloroplatinum‐treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells

Cancer

Volumn 71, Issue 4, 1993, Pages 1313-1321

  Mizutani, Youichi ^a   Bonavida, Benjamin ^a   Nio, Yoshinori ^b   Yoshida, Osamu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cis diamminedichloroplatinum; K562; natural killer cell activity; target susceptibility

Indexed keywords

ALPHA INTERFERON; CARBOPLATIN; CHLOROQUINE; CISPLATIN; CYTOTOXIC FACTOR; GAMMA INTERFERON; LEUCINE METHYL ESTER; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NERVE CELL ADHESION MOLECULE; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; BLADDER TUMOR; CELL STRAIN K 562; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; URINARY TRACT DISEASE;

AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CARBOPLATIN; CHLOROQUINE; CISPLATIN; CYTOTOXICITY, IMMUNOLOGIC; DIPEPTIDES; FEMALE; HUMAN; IMMUNOSUPPRESSIVE AGENTS; INTERFERONS; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LYMPHOKINES; MALE; MIDDLE AGE; PROTEINS; STEREOISOMERISM; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR;

EID: 0027446372     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19930215)71:4<1313::AID-CNCR2820710424>3.0.CO;2-#     Document Type: Article

References (47)

1. Immunosuppressive agents
2. Effect of chemotherapeutic agents on natural cell‐mediated cytotoxicity in mice
3. Augmentation of the human immune response by cyclophosphamide
4. Immunoregulation by cancer chemotherapeutic agents
5. Effect of adriamycin and cyclophosphamide treatment on induction of macrophage cytotoxic function in mice
6. In vitro tumor cell killing by peritoneal macrophages from mitomycin‐C treated rats
7. The influence of methotrexate and thymidine on the human natural killer cell function in vitro
8. Activation of tumor‐cytostatic macrophages with the antitumor agent 9,10‐anthracene‐dicarboxaldehyde bis [(4,5‐dihydro‐1H‐imidazole‐2‐yl) hydrazone] dihydrochloride (bisantrene)
9. Platinum compounds: a new class of potent antitumor agents
10. Cisplatin, etoposide, bleomycin first line therapy and early resection of residual tumor in far‐advanced germinal testis cancer
11. Preliminary results of M‐VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium
12. 2] on the mixed lymphocyte tumor assay
13. Enhancement of natural killer cytotoxicity by cis‐Diamminedichloroplatinum (II) in vivo and in vitro
14. Enhancement of naturally occurring human spontaneous monocyte mediated cytotoxicity by cis‐diamminedichloroplatinum (II)
15. Defective monocyte killing in patients with malignancies and restoration of function during chemotherapy
16. Induction of lymphokine‐activated killer‐like cells by cancer chemotherapy
17. Natural killer cells: definition, heterogenenity, lytic mechanism, functions and clinical application
18. Natural killer cells: history, relevance, and clinical application
19. Enhancement by x‐ray irradiation of target cell susceptibility to natural killer cells
20. Activation by the protein‐bound poly‐saccharide PSK (Krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer
21. Effects of bacillus Calmette‐Guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer
22. The streptococcal preparation OK‐432 specifically augments the susceptibility of human urinary bladder tumor cells to the autologous peripheral blood lymphocytes
23. Human chronic myelogenous leukemia cell‐line with positive Philadelphia chromosome
24. Studies on the mechanism of natural killer cytotoxicity: I. release of cytotoxic factors specific for NK‐sensitive target cells (NKCF) during coculture of NK effector cells with NK target cells
25. Studies on the mechanism of natural killer cytotoxicity: VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor
26. Production of an anticancer cytotoxin by human monocytes
27. Tumor cell lipid composition and sensitivity to humoral immune killing: I. modification of cellular lipid and fatty acid content by metabolic inhibitors and hormones
28. Metabolic inhibitors render “resistant” target cells sensitive to natural killer‐cell‐mediated lysis
29. Effects of cis‐dichlorodiammine platinum (II) on DNA synthesis in kidney and other tissues of normal and tumor‐bearing rats
30. Platinum analogues
31. Structure activity relationships of the antitumor platinum coordination complexes
32. Antitumor, toxic, and biochemical properties of cisplatin and eight other platinum complexes
33. Studies on the antitumor activity of group VIII transition metal complexes: Part I. platinum (II) complexes
34. Possible mechanism for the antitumor activity of platinum coordination complexes
35. Ultrastructural changes of sarcoma‐180 cells after treatment with cis‐dichlorodiammine platinum (II), in vivo and in vitro
36. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents
37. Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling
38. Action of lysosomotrophic amines on spontaneous and interferon enhanced NK and CTL cytolysis
39. Induction of tumor necrosis factor expression and resistance in a human breast tumor cells
40. Tumor necrosis factor expression in human epithelial tumor cell lines
41. Production and secretion of BSF2/IL6 in a case of hairy cell leukemia with polyclonal hypergammaglobulinemia
42. Correlation between lymphocyte‐mediated auto‐tumor reactivities and clinical course: I. evaluation of 46 patients with sarcoma
43. Natural killer activity and head and neck cancer: a clinical assessment
44. Antiviral activity induced by culturing lymphocytes with tumor‐derived or virus‐transformed cells: enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis
45. Clinical immunotherapy studies in the Surgery Branch of the US National Cancer Institute: brief review
46. Modulation by cisdiamminedi‐chloroplatinum (II) (CDDP) of the susceptibilities of human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells to peripheral blood lymphocytes and lymphokine activated killer (LAK) cells